1. Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

   • Cédric Ménard
   • François Martin
   • François Ghiringhelli

   Review 28 March 2008 Pages: 1579 - 1587

   

2. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E₂ results in high interleukin-12 production and cell migration

   • A. C. Inge Boullart
   • Erik H. J. G. Aarntzen
   • I. Jolanda M. de Vries

   Original Article Open access 06 March 2008 Pages: 1589 - 1597

   

3. Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

   • Jaafar Bennouna
   • Emmanuelle Bompas
   • Sylvie Négrier

   Original Article 27 February 2008 Pages: 1599 - 1609

   

4. Cooperation of adenosine and prostaglandin E₂ (PGE₂) in amplification of cAMP–PKA signaling and immunosuppression

   • Yunyun Su
   • Xiaojun Huang
   • Elieser Gorelik

   Original Article 08 March 2008 Pages: 1611 - 1623

   

5. Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen

   • Michela Croce
   • Raffaella Meazza
   • Silvano Ferrini

   Original Article 07 March 2008 Pages: 1625 - 1634

   

6. Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer

   • Benjamin B. Williams
   • Meg Wall
   • Robert G. Ramsay

   Original Article 03 April 2008 Pages: 1635 - 1645

   

7. Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling

   • Hirobumi Asai
   • Hiroko Iijima
   • Koutaro Maeda

   Original Article 15 March 2008 Pages: 1647 - 1655

   

8. Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responses

   • Jian-Qing Gao
   • Naoko Kanagawa
   • Shinsaku Nakagawa

   Original Article 08 March 2008 Pages: 1657 - 1664

   

9. Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells

   • Patrizia Stoitzner
   • Laura K. Green
   • Franca Ronchese

   Original Article 01 March 2008 Pages: 1665 - 1673

   

10. Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells

    • Patrizia Stoitzner
    • Laura K. Green
    • Franca Ronchese

    Erratum 05 June 2008 Pages: 1675 - 1675

11. Progress in Vaccination against Cancer 2007 (PIVAC 7)

    Symposium Paper 26 August 2008 Pages: 1677 - 1677

12. A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity

    • Jay A. Berzofsky
    • Masaki Terabe

    Symposium Paper 28 March 2008 Pages: 1679 - 1683

    

13. Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?

    • Raffaele Adolfo Calogero
    • Elena Quaglino
    • Federica Cavallo

    Symposium Paper 20 February 2008 Pages: 1685 - 1694

    

14. Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors

    • Hyun-Il Cho
    • Guilian Niu
    • Esteban Celis

    Symposium Paper 06 February 2008 Pages: 1695 - 1703

    

15. Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia

    • M. Palma
    • L. Adamson
    • A. Choudhury

    Symposium Paper 29 July 2008 Pages: 1705 - 1710

16. The “A, B and C” of Her-2 DNA vaccine development

    • Wei-Zen Wei
    • Jennifer Jacob
    • Yi-chi M. Kong

    Symposium Paper 14 February 2008 Pages: 1711 - 1717

    

17. Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

    • Barbara Seliger

    Symposium Paper 12 April 2008 Pages: 1719 - 1726

    

18. Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

    • Natalia Aptsiauri
    • Rafael Carretero
    • Federico Garrido

    Symposium Paper 20 May 2008 Pages: 1727 - 1733

    

19. Cancer treatment: the combination of vaccination with other therapies

    • Mads Hald Andersen
    • Rikke Bæk Sørensen
    • Per thor Straten

    Symposium Paper Open access 20 February 2008 Pages: 1735 - 1743